Jun‐ichiro Inoue

Active 1986–2025

Also published as
Jun-ichiro Inoue · Jun-Ichiro Inoue
111
Papers
24,512
Citations
76
h-index
107
i10-index

Citations

Citations per year for Jun‐ichiro Inoue1957: 1 citations1980: 2 citations1986: 3 citations1987: 24 citations1988: 64 citations1989: 63 citations1990: 58 citations1991: 61 citations1992: 102 citations1993: 132 citations1994: 56 citations1995: 76 citations1996: 82 citations1997: 90 citations1998: 138 citations1999: 161 citations2000: 184 citations2001: 190 citations2002: 252 citations2003: 337 citations2004: 251 citations2005: 431 citations2006: 390 citations2007: 338 citations2008: 313 citations2009: 339 citations2010: 224 citations2011: 177 citations2012: 248 citations2013: 185 citations2014: 180 citations2015: 163 citations2016: 132 citations2017: 160 citations2018: 177 citations2019: 486 citations2020: 729 citations2021: 597 citations2022: 426 citations2023: 269 citations2024: 395 citations2025: 173 citations2026: 6 citations1958–1979: no citations, so these years are not shown1981–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,868 citing papers, 30.4% of this breakdownJapan: 1,130 citing papers, 12% of this breakdownChina: 1,101 citing papers, 11.7% of this breakdownUnited Kingdom: 511 citing papers, 5.4% of this breakdownGermany: 488 citing papers, 5.2% of this breakdownFrance: 323 citing papers, 3.4% of this breakdownCanada: 283 citing papers, 3% of this breakdownSouth Korea: 258 citing papers, 2.7% of this breakdownAustralia: 239 citing papers, 2.5% of this breakdownItaly: 178 citing papers, 1.9% of this breakdownIndia: 175 citing papers, 1.9% of this breakdownNetherlands: 127 citing papers, 1.3% of this breakdown
0%30.4%Other 18.6%

Fields

  • Biochemistry, Genetics and Molecular Biology44.2%
  • Immunology and Microbiology26.3%
  • Medicine22.8%
  • Neuroscience1.8%
  • Nursing0.9%
  • Agricultural and Biological Sciences0.9%
  • Other3.1%

Topics

  • NF-κB Signaling Pathways8.5%
  • Immune Response and Inflammation7.6%
  • interferon and immune responses4.7%
  • Bone Metabolism and Diseases4.5%
  • Immune Cell Function and Interaction2.7%
  • Cytokine Signaling Pathways and Interactions2.4%
  • Other69.6%

Coauthors

All papers

Open in search
  1. Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

    Authors: , , , , , , , , , , , , , - Developmental Cell 2002 cited by 2,679

  2. TAK1 is a ubiquitin-dependent kinase of MKK and IKK

    Authors: , , , , , - Nature 2001 cited by 2,117

  3. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

    Authors: , , , , , , , , , , , - Nature Immunology 2004 cited by 1,013

  4. Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes

    Authors: , , , , , , , - The Journal of Immunology 2001 cited by 1,092

  5. TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-κB activation

    Authors: , , , - Japan Academy Series B, Proceedings of the Japan Academy Series B 2006 cited by 74

  6. The Tumor Necrosis Factor Family Receptors RANK and CD40 Cooperatively Establish the Thymic Medullary Microenvironment and Self-Tolerance

    Authors: , , , , , , , , , , , , , - Immunity 2008 cited by 495

  7. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

    Authors: , , , , , , , , , , , , , - Viruses 2020 cited by 293

  8. The Cytokine RANKL Produced by Positively Selected Thymocytes Fosters Medullary Thymic Epithelial Cells that Express Autoimmune Regulator

    Authors: , , , , , , , , , , , , , , , - Immunity 2008 cited by 435

  9. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway

    Authors: , , , , , - Nature 1999 cited by 1,194

  10. Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity

    Authors: , , , , , , , , , , - Nature Structural & Molecular Biology 2015 cited by 136

  11. Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis

    Authors: , , , , , , - The EMBO Journal 2001 cited by 465

  12. TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-κB, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase

    Authors: , , , , , , , - The Journal of Immunology 2000 cited by 246

  13. RANK‐mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis

    Authors: , , , , , - The EMBO Journal 2005 cited by 224

  14. Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice

    Authors: , , , , , , , , , , - Genes to Cells 1999 cited by 638

  15. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases

    Authors: , , , , , , , - International Immunology 1999 cited by 372

  16. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay

    Authors: , , , , , , - Antimicrobial Agents and Chemotherapy 2016 cited by 353

  17. Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling

    Authors: , , - The Journal of Immunology 2004 cited by 311

  18. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response

    Authors: , , , , , , , , , , , , , , - Nature 2012 cited by 180

  19. TRAF6 Establishes Innate Immune Responses by Activating NF-κB and IRF7 upon Sensing Cytosolic Viral RNA and DNA

    Authors: , , , , , , , , , , , , , , , - PLoS ONE 2009 cited by 120

  20. NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype

    Authors: , , , , , - Nature Communications 2013 cited by 197

  21. Human lactoferrin activates NF‐κB through the Toll‐like receptor 4 pathway while it interferes with the lipopolysaccharide‐stimulated TLR4 signaling

    Authors: , , , , , , , , , , , , - FEBS Journal 2010 cited by 120

  22. Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cardiovascular Research 2024 cited by 23

  23. Different Cytokines Induce Surface Lymphotoxin-αβ on IL-7 Receptor-α Cells that Differentially Engender Lymph Nodes and Peyer's Patches

    Authors: , , , , , , , , - Immunity 2002 cited by 242

  24. NF‐κB activation in development and progression of cancer

    Authors: , , , - Cancer Science 2007 cited by 234